Hospitals and cancer care givers can now offer the IndiTreat test to their cancer patients.
Already in 2020, cancer patients in selected hospitals can receive IndiTreat-guided medical treatment.
The IndiTreat® analysis tool, a 2cureX proprietary technology, makes it possible to match the patients’ cancer disease with the most effective treatment.
2cureX is in the process of making IndiTreat available in selected hospitals around Europe.
Read article here: Life Science Berlingske Medier December 2019 (article is in Danish)